Expediency
发表于 2025-3-25 04:04:02
M. Meißner,M. Doggett,J. Hirche,U. Kanusvenues of pharmacotherapy, we must rely upon imperfect, evolving knowledge about disease states and inferences we may make based upon a similarly incomplete appreciation of the mechanism of action of drugs known to be effective against clinical targets.
热心助人
发表于 2025-3-25 11:19:22
http://reply.papertrans.cn/29/2831/283067/283067_22.png
财产
发表于 2025-3-25 12:14:44
Overview: 978-1-4612-9180-0978-1-4612-4828-6
PRISE
发表于 2025-3-25 18:39:20
http://reply.papertrans.cn/29/2831/283067/283067_24.png
Esalate
发表于 2025-3-25 21:37:40
http://reply.papertrans.cn/29/2831/283067/283067_25.png
清晰
发表于 2025-3-26 04:11:45
http://reply.papertrans.cn/29/2831/283067/283067_26.png
Arteriography
发表于 2025-3-26 06:59:11
http://image.papertrans.cn/e/image/283067.jpg
Deference
发表于 2025-3-26 09:17:43
http://reply.papertrans.cn/29/2831/283067/283067_28.png
anesthesia
发表于 2025-3-26 16:09:27
http://reply.papertrans.cn/29/2831/283067/283067_29.png
摸索
发表于 2025-3-26 18:41:56
Clinical Evaluation of Drug Candidates than 10 years of research and approximately $65 million may be required from the time of original identification or synthesis of a compound to its commercial introduction as a marketed drug. The majority of the time and money are usually spent on clinical development.